Cargando…

CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells

OBJECTIVE: Bone metastasis is a clinically important outcome of prostate carcinoma (PC). We focused on the phenotypic and functional characterization of a particularly aggressive phenotype within the androgen-independent bone metastasis-derived PC3 cell line. These cells, originated from the spontan...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontanella, Rosaria A., Sideri, Silvia, Di Stefano, Chiara, Catizone, Angiolina, Di Agostino, Silvia, Angelini, Daniela F., Guerrera, Gisella, Battistini, Luca, Battafarano, Giulia, Del Fattore, Andrea, Campese, Antonio Francesco, Padula, Fabrizio, De Cesaris, Paola, Filippini, Antonio, Riccioli, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330537/
https://www.ncbi.nlm.nih.gov/pubmed/34018387
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0495
_version_ 1783732740134273024
author Fontanella, Rosaria A.
Sideri, Silvia
Di Stefano, Chiara
Catizone, Angiolina
Di Agostino, Silvia
Angelini, Daniela F.
Guerrera, Gisella
Battistini, Luca
Battafarano, Giulia
Del Fattore, Andrea
Campese, Antonio Francesco
Padula, Fabrizio
De Cesaris, Paola
Filippini, Antonio
Riccioli, Anna
author_facet Fontanella, Rosaria A.
Sideri, Silvia
Di Stefano, Chiara
Catizone, Angiolina
Di Agostino, Silvia
Angelini, Daniela F.
Guerrera, Gisella
Battistini, Luca
Battafarano, Giulia
Del Fattore, Andrea
Campese, Antonio Francesco
Padula, Fabrizio
De Cesaris, Paola
Filippini, Antonio
Riccioli, Anna
author_sort Fontanella, Rosaria A.
collection PubMed
description OBJECTIVE: Bone metastasis is a clinically important outcome of prostate carcinoma (PC). We focused on the phenotypic and functional characterization of a particularly aggressive phenotype within the androgen-independent bone metastasis-derived PC3 cell line. These cells, originated from the spontaneous conversion of a CD44-negative subpopulation, stably express the CD44v8-10 isoform (CD44v8-10(pos)) and display stem cell-like features and a marked invasive phenotype in vitro that is lost upon CD44v8-10 silencing. METHODS: Flow cytometry, enzyme-linked immunoassay, immunofluorescence, and Western blot were used for phenotypic and immunologic characterization. Real-time quantitative polymerase chain reaction and functional assays were used to assess osteomimicry. RESULTS: Analysis of epithelial–mesenchymal transition markers showed that CD44v8-10(pos) PC3 cells surprisingly display epithelial phenotype and can undergo osteomimicry, acquiring bone cell phenotypic and behavioral traits. Use of specific siRNA evidenced the ability of CD44v8-10 variant to confer osteomimetic features, hence the potential to form bone-specific metastasis. Moreover, the ability of tumors to activate immunosuppressive mechanisms which counteract effective immune responses is a sign of the aggressiveness of a tumor. Here we report that CD44v8-10(pos) cells express programmed death ligand 1, a negative regulator of anticancer immunity, and secrete exceptionally high amounts of interleukin-6, favoring osteoclastogenesis and immunosuppression in bone microenvironment. Notably, we identified a novel pathway activated by CD44v8-10, involving tafazzin (TAZ) and likely the Wnt/TAZ axis, known to play a role in upregulating osteomimetic genes. CONCLUSIONS: CD44v8-10 could represent a marker of a more aggressive bone metastatic PC population exerting a driver role in osteomimicry in bone. A novel link between TAZ and CD44v8-10 is also shown.
format Online
Article
Text
id pubmed-8330537
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Compuscript
record_format MEDLINE/PubMed
spelling pubmed-83305372021-08-09 CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells Fontanella, Rosaria A. Sideri, Silvia Di Stefano, Chiara Catizone, Angiolina Di Agostino, Silvia Angelini, Daniela F. Guerrera, Gisella Battistini, Luca Battafarano, Giulia Del Fattore, Andrea Campese, Antonio Francesco Padula, Fabrizio De Cesaris, Paola Filippini, Antonio Riccioli, Anna Cancer Biol Med Original Article OBJECTIVE: Bone metastasis is a clinically important outcome of prostate carcinoma (PC). We focused on the phenotypic and functional characterization of a particularly aggressive phenotype within the androgen-independent bone metastasis-derived PC3 cell line. These cells, originated from the spontaneous conversion of a CD44-negative subpopulation, stably express the CD44v8-10 isoform (CD44v8-10(pos)) and display stem cell-like features and a marked invasive phenotype in vitro that is lost upon CD44v8-10 silencing. METHODS: Flow cytometry, enzyme-linked immunoassay, immunofluorescence, and Western blot were used for phenotypic and immunologic characterization. Real-time quantitative polymerase chain reaction and functional assays were used to assess osteomimicry. RESULTS: Analysis of epithelial–mesenchymal transition markers showed that CD44v8-10(pos) PC3 cells surprisingly display epithelial phenotype and can undergo osteomimicry, acquiring bone cell phenotypic and behavioral traits. Use of specific siRNA evidenced the ability of CD44v8-10 variant to confer osteomimetic features, hence the potential to form bone-specific metastasis. Moreover, the ability of tumors to activate immunosuppressive mechanisms which counteract effective immune responses is a sign of the aggressiveness of a tumor. Here we report that CD44v8-10(pos) cells express programmed death ligand 1, a negative regulator of anticancer immunity, and secrete exceptionally high amounts of interleukin-6, favoring osteoclastogenesis and immunosuppression in bone microenvironment. Notably, we identified a novel pathway activated by CD44v8-10, involving tafazzin (TAZ) and likely the Wnt/TAZ axis, known to play a role in upregulating osteomimetic genes. CONCLUSIONS: CD44v8-10 could represent a marker of a more aggressive bone metastatic PC population exerting a driver role in osteomimicry in bone. A novel link between TAZ and CD44v8-10 is also shown. Compuscript 2021-08-15 2021-08-15 /pmc/articles/PMC8330537/ /pubmed/34018387 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0495 Text en Copyright: © 2021, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0 (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Article
Fontanella, Rosaria A.
Sideri, Silvia
Di Stefano, Chiara
Catizone, Angiolina
Di Agostino, Silvia
Angelini, Daniela F.
Guerrera, Gisella
Battistini, Luca
Battafarano, Giulia
Del Fattore, Andrea
Campese, Antonio Francesco
Padula, Fabrizio
De Cesaris, Paola
Filippini, Antonio
Riccioli, Anna
CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
title CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
title_full CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
title_fullStr CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
title_full_unstemmed CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
title_short CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
title_sort cd44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330537/
https://www.ncbi.nlm.nih.gov/pubmed/34018387
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0495
work_keys_str_mv AT fontanellarosariaa cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT siderisilvia cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT distefanochiara cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT catizoneangiolina cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT diagostinosilvia cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT angelinidanielaf cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT guerreragisella cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT battistiniluca cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT battafaranogiulia cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT delfattoreandrea cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT campeseantoniofrancesco cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT padulafabrizio cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT decesarispaola cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT filippiniantonio cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells
AT ricciolianna cd44v810isamarkerformalignanttraitsandapotentialdriverofbonemetastasisinasubpopulationofprostatecancercells